Related references
Note: Only part of the references are listed.Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma
Bjoern Chapuy et al.
CANCER CELL (2013)
The Membrane-Bound Enzyme CD38 Exists in Two Opposing Orientations
Yong Juan Zhao et al.
SCIENCE SIGNALING (2012)
Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors
Michel de Weers et al.
JOURNAL OF IMMUNOLOGY (2011)
Erythrocyte CD38 as a prognostic marker in cancer
Isil Albeniz et al.
HEMATOLOGY (2007)
Evidence of an immunologic mechanism behind the therapeutical effects of arsenic trioxide (As2O3) on myeloma cells
S Deaglio et al.
LEUKEMIA RESEARCH (2001)
Share Paper
